Ogawa Chikara

Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression

M. Kudo, Y. Hiasa, J. Tani, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.